|
|
Blood, 1 September 2004, Vol. 104, No. 5, pp. 1419-1427.
Prepublished online as a Blood First Edition Paper on May 20, 2004; DOI 10.1182/blood-2004-01-0201.
Previous Article | Next Article 
Submitted January 20, 2004
Accepted May 2, 2004
A Dose Effect of IL-7 on Thymocyte Development
Nahed El Kassar, Philip J Lucas, David B Klug, Monica Zamisch, Melinda Merchant, Catherine V Bare, Baishakhi Choudhury, Susan O Sharrow, Ellen Richie, Crystal L Mackall, and Ronald E Gress*
National Cancer Institute, Experimental Immunology Branch, National Institutes of Health, Bethesda, MD, USA
MD Anderson Cancer Center, Dept. of Carcinogenesis, University of Texas, Smithville, TX, USA
National Cancer Institute, Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD, USA
* Corresponding author; email: gressr{at}exchange.nih.gov.
To study IL-7 in early thymocyte development, we generated mice transgenic (Tg) for the IL-7 gene under control of the lck proximal promoter. Founder line TgA, with the lowest level of IL-7 over-expression, showed enhanced  T-cell development. In contrast, in the highest over-expressing founder line, TgB,  T-cell development was disturbed with a block at the earliest intra-thymic precursor stage. This was due to decreased progenitor proliferation as assessed by Ki-67 staining and in vivo BrdU incorporation. Bcl-2 was up-regulated in T-cell committed progenitors in all Tg lines, and accounted for greater numbers of DP, CD4SP and CD8SP thymocytes in TgA mice where, in contrast to TgB mice, thymocyte progenitor proliferation was normal. Mixed marrow chimeras using TgB+ and congenic mice as donors, and experiments utilizing anti- IL-7 MAb in vivo, confirmed the role of IL-7 protein in the observed TgB phenotype. In conclusion, at low Tg over-expression, IL-7 enhanced  T-cell development by increasing thymocyte progenitor survival while at high over-expression, IL-7 reduces their proliferation, inducing a dramatic block in DP production. These results show for the first time in vivo, a dose effect of IL-7 on  T-cell development and has implications for IL-7 in the clinical setting.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Bessette, M. L. Lang, R. A. Fava, M. Grundy, J. Heinen, L. Horne, R. Spolski, A. Al-Shami, H. C. Morse III, W. J. Leonard, et al.
A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling
Blood,
January 1, 2008;
111(1):
344 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bruinsma, P. L. van Soest, P. J. M. Leenen, B. N. Lambrecht, T. Cupedo, B. Lowenberg, J. J. Cornelissen, and E. Braakman
Keratinocyte Growth Factor Induces Expansion of Murine Peripheral CD4+Foxp3+ Regulatory T Cells and Increases Their Thymic Output
J. Immunol.,
December 1, 2007;
179(11):
7424 - 7430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Clise-Dwyer, G. E. Huston, A. L. Buck, D. K. Duso, and S. L. Swain
Environmental and Intrinsic Factors Lead to Antigen Unresponsiveness in CD4+ Recent Thymic Emigrants from Aged Mice
J. Immunol.,
February 1, 2007;
178(3):
1321 - 1331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Swainson, S. Kinet, C. Mongellaz, M. Sourisseau, T. Henriques, and N. Taylor
IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway
Blood,
February 1, 2007;
109(3):
1034 - 1042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Swainson, E. Verhoeyen, F.-L. Cosset, and N. Taylor
IL-7R{alpha} Gene Expression Is Inversely Correlated with Cell Cycle Progression in IL-7-Stimulated T Lymphocytes.
J. Immunol.,
June 1, 2006;
176(11):
6702 - 6708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Henson, R. Snelgrove, T. Hussell, D. J. Wells, and R. Aspinall
An IL-7 Fusion Protein That Shows Increased Thymopoietic Ability
J. Immunol.,
September 15, 2005;
175(6):
4112 - 4118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Fry and C. L. Mackall
The Many Faces of IL-7: From Lymphopoiesis to Peripheral T Cell Maintenance
J. Immunol.,
June 1, 2005;
174(11):
6571 - 6576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Shultz, B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, et al.
Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2R{gamma}null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells
J. Immunol.,
May 15, 2005;
174(10):
6477 - 6489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zamisch, B. Moore-Scott, D.-m. Su, P. J. Lucas, N. Manley, and E. R. Richie
Ontogeny and Regulation of IL-7-Expressing Thymic Epithelial Cells
J. Immunol.,
January 1, 2005;
174(1):
60 - 67.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Munitic, J. A. Williams, Y. Yang, B. Dong, P. J. Lucas, N. El Kassar, R. E. Gress, and J. D. Ashwell
Dynamic regulation of IL-7 receptor expression is required for normal thymopoiesis
Blood,
December 15, 2004;
104(13):
4165 - 4172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yu, B. Erman, J.-H. Park, L. Feigenbaum, and A. Singer
IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and ROR{gamma}t: Impact on Thymocyte Development
J. Exp. Med.,
September 20, 2004;
200(6):
797 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|